JMDC Inc
TSE:4483
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
JMDC Inc
Tax Provision
JMDC Inc
Tax Provision Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
JMDC Inc
TSE:4483
|
Tax Provision
-¥3.3B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
|
M3 Inc
TSE:2413
|
Tax Provision
-¥22.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-14%
|
|
|
S
|
Software Service Inc
TSE:3733
|
Tax Provision
-¥2.2B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-9%
|
|
|
Medley Inc
TSE:4480
|
Tax Provision
-¥1.4B
|
CAGR 3-Years
-41%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CareNet Inc
TSE:2150
|
Tax Provision
-¥994.5m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-46%
|
|
|
Medical Data Vision Co Ltd
TSE:3902
|
Tax Provision
¥210.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
JMDC Inc
Glance View
Amidst the complex intersection of healthcare and technology, JMDC Inc. has carved a unique niche by harnessing the power of big data to improve healthcare outcomes and efficiency. Founded in Japan, the company stands as a beacon in the health informatics sector, meticulously collecting and analyzing health-related data drawn from a variety of sources, including medical claims, health screenings, and electronic health records. By transforming this extensive data trove into actionable insights, JMDC offers healthcare providers, pharmaceutical companies, and insurance firms the analytics they need to make informed decisions. Key to JMDC's operation is its commitment to safeguarding patient anonymity while extracting valuable insights that can streamline healthcare delivery, enhance pharmaceutical research, and optimize insurance underwriting. JMDC's revenue model hinges on the sale of its aggregated data and analytics solutions to a vast array of stakeholders in the medical field. Pharmaceutical companies, eager to understand drug efficacy and patient demographics better, turn to JMDC for data-driven insights that can influence drug development and marketing strategies. Insurance companies leverage JMDC's data to refine their offerings and better assess risk, ensuring competitive pricing models and improved customer satisfaction. Moreover, healthcare providers utilize this analytics backbone to enhance operational efficiency and improve patient care outcomes. Through licensing agreements and subscription-based services, JMDC effectively monetizes its data resources, achieving sustained growth in an industry that increasingly values the marriage of technology and healthcare.
See Also
What is JMDC Inc's Tax Provision?
Tax Provision
-3.3B
JPY
Based on the financial report for Dec 31, 2025, JMDC Inc's Tax Provision amounts to -3.3B JPY.
What is JMDC Inc's Tax Provision growth rate?
Tax Provision CAGR 5Y
-27%
Over the last year, the Tax Provision growth was -32%. The average annual Tax Provision growth rates for JMDC Inc have been -23% over the past three years , -27% over the past five years .